SAN FRANCISCO, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX), a leading provider of expert systems that inform therapeutic decision-making in oncology, today announced that it will hold an investor conference call on August 14, 2014 to discuss the Company's financial results for the first quarter of fiscal 2015 and to provide an update about the business in the current fiscal year.
The dial-in number for the live audio call beginning on Thursday, August 14, 2014, at 5 p.m. EDT (2 p.m. PDT) is 1-800-868-1837 for all participants. The conference identification number is 185118#. A live webcast of the conference call will also be available at:
https://webconf1.conferencedownload.com/. The conference dial in for the webcast is 18008681837 and the conference code will be 185118.
A webcast replay of the call will be available for one year and may be accessed at the same link: https://webconf1.conferencedownload.com/.
About CollabRx
CollabRx, Inc. (NASDAQ: CLRX) is a data analytics company and a leader in cloud-based expert systems to inform health care decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at http://www.collabrx.com.
CollabRx Contacts:
Thomas R. Mika, CEO
CollabRx, Inc.
415-248-5350
Dian Griesel, Inc.
860-619-0177
dmanchester(at)dgicomm(dot)com
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/08/prweb12061374.htm